Cathal Friel-chaired Poolbeg Pharma’s shares plunge on US tie-up talks
Donegal native has been behind a number of pharma deals in past decade
Poolbeg Pharma
Ireland’s Mr IPO and his plans to make more companies public
Cathal Friel shows no sign of slowing down after a busy week which saw him sell his remaining stake in Hvivo
Glandore’s Michael Kelly increases his stake in Poolbeg Pharma
Most recent acquisition makes managing director the company’s second-largest shareholder after founder Cathal Friel
Poolbeg Pharma expands treatment into new markets
Company signs strategic collaboration agreement with a Nasdaq listed biopharma company
Poolbeg Pharma gets go-ahead for Japanese patent of ‘blockbuster’ influenza treatment
It is expected that granting of the application will follow upon completion of formalities.
Poolbeg Pharma uses AI to identify potential drug targets for flu treatment
Biopharmaceutical company hails work with CytoReason as ‘significant breakthrough’
Poolbeg Pharma granted US patent related to influenza drug
Company recently reported positive data from POLB 001 human challenge trial
Poolbeg Pharma releases positive data from influenza trial
Treatment is strain agnostic, and is being developed to treat acute inflammatory conditions
Poolbeg Pharma sees positive test results for new flu drug
No further clinical activity required, bringing the recruitment and clinical phase to a close on schedule
Poolbeg Pharma sees artificial intelligence breakthrough in RSV drug discovery
Company has been working with OneThree Biotech to us artificial intelligence to identify novel drug targets for RSV treatment
US likely to allow Poolbeg application to expand intellectual property protection for influenza drug
Open Orphan spinout has applied for extra intellectual property protection for uses against other illnesses
Investors to buy €1.9m shares in Poolbeg Pharma
Largest individual investor understood to be an experienced life science investor
Poolbeg Pharma signs deal with AI company on influenza data
Project could yield new and better treatments for disease
Poolbeg Pharma gets licence to develop respiratory treatment
Immunotherapy could be used to treat conditions such as influenza and Covid-19
Poolbeg Pharma agrees option agreement with UCD
Company signs licence for MelioVac, a pre-clinical vaccine for melioidosis
NatWest to take Permanent TSB stake in Ulster Bank loans transfer
Seen & heard: global tax rate above 15%; phasing out leasing of social housing; Poolbeg to seek Nasdaq listing
European shares fall after Fed signals early policy tightening
Ryanair the main market mover in Dublin as it rises 3% while Glanbia and AIB dip
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Six Nations 2025
Get the latest news, analysis and match reports from the M6N and W6N championships
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices